Delivery Order SPE2DB25D3008-SPE2DB25FRBQE

Award Date 3/24/25
Potential Completion Date 3/25/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of KERENDIA 10 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $3,165.03 and a completion date of March 11, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,970.95, is for the delivery of Kerendia 10 mg tablets. The contract has an ultimate completion date of November 13, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $25,712.05 and is for the supply of Kerendia 10 mg tablets. The contract is a firm fixed price delivery order, with an ultimate completion date of September 22, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,712.13, is for the delivery of KERENDIA 10 MG TABLET 30S, a medical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,068.15 firm fixed price delivery order is for the supply of KERENDIA 10 MG TABLET 90S, a pharmaceutical product. The award has an ultimate completion date of April 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,638.95 Firm Fixed Price delivery order contract is for the supply of KERENDIA 10 MG TABLET 30S medication. The contract has an ultimate completion date of February 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KERENDIA 10 MG TABLET 30S. The Delivery Order, valued at $10,798.86, was issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a $999,999,999 contract covering a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,435.81 firm fixed-price delivery order is for the supply of KERENDIA 10 MG TABLET 30S, a pharmaceutical product, with a completion date of March 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,104.49 firm-fixed-price contract is for the supply of KERENDIA 10 MG TABLET 90S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $74,292.56 Firm Fixed Price Delivery Order contract is for the delivery of KERENDIA 10 MG TABLET 90S, a medication used to treat patients. The contract has a ceiling value of $74,292.56 and an ultimate completion date of November 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB25D3008
    Indefinite Delivery Contract
  • SPE2DB25D3008-SPE2DB25FRBQE
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of KERENDIA 10 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,146.75 and a completion date of March 25, 2025.

The contract is an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors. The contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 6/29/25, 12:47 AM